Advisor Group Holdings, Inc. Synaptogenix, Inc. Put Options Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SNPX
# of Institutions
1Shares Held
30KCall Options Held
0Put Options Held
0About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $21M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...